Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

PRIMA US-Feasibility Study in Atrophic Dry AMD

NCT: NCT03392324 · COMPLETED

NCT IDNCT03392324
StatusCOMPLETED
Start Date2018-04-26
Completion2026-05-20
SponsorScience Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

In this early feasibility trial the safety and performance of the new retinal prothesis PRIMA is tested in five subjects suffering from atrophic dry age related macular degeneration.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑